PGT-A in IVF: Key Factors for Decision-Making

A 2021 study of 37 IVF patients found that decisions to use Preimplantation Genetic Testing for Aneuploidy (PGT-A) are influenced by factors like age, pregnancy history, and personal values. PGT-A reduces chromosomal abnormalities by 90%, improving IVF success rates for women over 40, who face an 80% risk of aneuploidy.

---

Key Takeaways

Age and Aneuploidy Risk: Why Older Women Benefit from PGT-A

Women over 40 have an 80% risk of aneuploidy in embryos. PGT-A screens for chromosomal abnormalities, reducing miscarriage risk and increasing IVF success rates by prioritizing euploid embryos for transfer.

Patient Values and Ethical Considerations in PGT-A Decisions

Patients opposing PGT-A often cite ethical concerns, such as avoiding embryo harm or rejecting interventions that require pregnancy termination. These values directly influence decisions against genetic screening.

How Past Pregnancy Losses Influence PGT-A Adoption

Women with a history of miscarriages or failed IVF cycles are more likely to choose PGT-A. A 2021 study found that prior pregnancy loss significantly increases willingness to adopt PGT-A to avoid recurrence.

Cost-Benefit Analysis of PGT-A for IVF Patients

While PGT-A adds financial burden, 40% of patients in the study viewed it as a necessary investment to improve success odds. Others hesitated due to existing IVF costs and uncertainty about ROI.

Educational Gaps in PGT-A Decision-Making

The study highlighted a need for better patient education on PGT-A’s limitations, including its inability to detect all abnormalities and the potential for false negatives. Clear communication from providers is critical for informed choices.

---

Source: Read full article